nodes	percent_of_prediction	percent_of_DWPC	metapath
Dronabinol—ABCB1—peripheral nervous system neoplasm	0.291	1	CbGaD
Dronabinol—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0675	0.114	CbGbCtD
Dronabinol—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0672	0.114	CbGbCtD
Dronabinol—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0576	0.0977	CbGbCtD
Dronabinol—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0496	0.084	CbGbCtD
Dronabinol—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0466	0.0789	CbGbCtD
Dronabinol—ABCG2—Vincristine—peripheral nervous system neoplasm	0.0287	0.0486	CbGbCtD
Dronabinol—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0267	0.0453	CbGbCtD
Dronabinol—ABCG2—Etoposide—peripheral nervous system neoplasm	0.0263	0.0445	CbGbCtD
Dronabinol—PTGS1—Etoposide—peripheral nervous system neoplasm	0.0243	0.0411	CbGbCtD
Dronabinol—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0242	0.041	CbGbCtD
Dronabinol—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0242	0.041	CbGbCtD
Dronabinol—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0232	0.0393	CbGbCtD
Dronabinol—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.0179	0.0304	CbGbCtD
Dronabinol—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0168	0.0284	CbGbCtD
Dronabinol—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0145	0.0246	CbGbCtD
Dronabinol—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0135	0.0229	CbGbCtD
Dronabinol—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0103	0.0175	CbGbCtD
Dronabinol—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00993	0.0168	CbGbCtD
Dronabinol—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00964	0.0163	CbGbCtD
Dronabinol—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00947	0.0161	CbGbCtD
Dronabinol—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00646	0.0109	CbGbCtD
Dronabinol—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00619	0.0105	CbGbCtD
Dronabinol—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00568	0.00962	CbGbCtD
Dronabinol—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00387	0.00656	CbGbCtD
Dronabinol—CNR1—GPCRs, Other—ADGRV1—peripheral nervous system neoplasm	0.00225	0.142	CbGpPWpGaD
Dronabinol—ABCG2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00089	0.056	CbGpPWpGaD
Dronabinol—ABCG2—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000518	0.0326	CbGpPWpGaD
Dronabinol—ABCG2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.000511	0.0321	CbGpPWpGaD
Dronabinol—CNR1—N-cadherin signaling events—PTPN11—peripheral nervous system neoplasm	0.000406	0.0255	CbGpPWpGaD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000336	0.0211	CbGpPWpGaD
Dronabinol—Fatigue—Topotecan—peripheral nervous system neoplasm	0.000332	0.00322	CcSEcCtD
Dronabinol—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00033	0.00319	CcSEcCtD
Dronabinol—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00033	0.00319	CcSEcCtD
Dronabinol—Ill-defined disorder—Alitretinoin—peripheral nervous system neoplasm	0.000329	0.00319	CcSEcCtD
Dronabinol—Decreased appetite—Melphalan—peripheral nervous system neoplasm	0.000328	0.00318	CcSEcCtD
Dronabinol—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.000326	0.00316	CcSEcCtD
Dronabinol—Fatigue—Melphalan—peripheral nervous system neoplasm	0.000325	0.00315	CcSEcCtD
Dronabinol—Tinnitus—Cisplatin—peripheral nervous system neoplasm	0.000324	0.00314	CcSEcCtD
Dronabinol—Flushing—Cisplatin—peripheral nervous system neoplasm	0.000323	0.00312	CcSEcCtD
Dronabinol—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000322	0.00312	CcSEcCtD
Dronabinol—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.00032	0.0031	CcSEcCtD
Dronabinol—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000318	0.00308	CcSEcCtD
Dronabinol—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000315	0.00305	CcSEcCtD
Dronabinol—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000315	0.00305	CcSEcCtD
Dronabinol—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000315	0.00305	CcSEcCtD
Dronabinol—Immune system disorder—Cisplatin—peripheral nervous system neoplasm	0.000314	0.00304	CcSEcCtD
Dronabinol—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.000314	0.00304	CcSEcCtD
Dronabinol—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000313	0.00303	CcSEcCtD
Dronabinol—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000313	0.00303	CcSEcCtD
Dronabinol—Cough—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.003	CcSEcCtD
Dronabinol—Mental disability—Epirubicin—peripheral nervous system neoplasm	0.000308	0.00299	CcSEcCtD
Dronabinol—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.000308	0.00298	CcSEcCtD
Dronabinol—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000305	0.00295	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000303	0.0191	CbGpPWpGaD
Dronabinol—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000302	0.00293	CcSEcCtD
Dronabinol—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000302	0.00293	CcSEcCtD
Dronabinol—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000302	0.00293	CcSEcCtD
Dronabinol—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000301	0.00292	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Alitretinoin—peripheral nervous system neoplasm	0.0003	0.00291	CcSEcCtD
Dronabinol—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000299	0.00289	CcSEcCtD
Dronabinol—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000298	0.00289	CcSEcCtD
Dronabinol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000296	0.00287	CcSEcCtD
Dronabinol—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000296	0.00286	CcSEcCtD
Dronabinol—Flushing—Etoposide—peripheral nervous system neoplasm	0.000296	0.00286	CcSEcCtD
Dronabinol—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000292	0.00283	CcSEcCtD
Dronabinol—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000291	0.00282	CcSEcCtD
Dronabinol—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000288	0.00279	CcSEcCtD
Dronabinol—Chills—Etoposide—peripheral nervous system neoplasm	0.000286	0.00277	CcSEcCtD
Dronabinol—Mental disability—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.00276	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000285	0.00276	CcSEcCtD
Dronabinol—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000284	0.00275	CcSEcCtD
Dronabinol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000284	0.00275	CcSEcCtD
Dronabinol—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.000283	0.00274	CcSEcCtD
Dronabinol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000282	0.00273	CcSEcCtD
Dronabinol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000282	0.00273	CcSEcCtD
Dronabinol—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000281	0.00273	CcSEcCtD
Dronabinol—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000281	0.00272	CcSEcCtD
Dronabinol—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00028	0.00271	CcSEcCtD
Dronabinol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000278	0.00269	CcSEcCtD
Dronabinol—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000277	0.00268	CcSEcCtD
Dronabinol—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000276	0.00268	CcSEcCtD
Dronabinol—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000274	0.00266	CcSEcCtD
Dronabinol—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000274	0.00266	CcSEcCtD
Dronabinol—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000274	0.00265	CcSEcCtD
Dronabinol—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000273	0.00264	CcSEcCtD
Dronabinol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000273	0.00264	CcSEcCtD
Dronabinol—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000272	0.00263	CcSEcCtD
Dronabinol—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000271	0.00262	CcSEcCtD
Dronabinol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000271	0.00262	CcSEcCtD
Dronabinol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000271	0.00262	CcSEcCtD
Dronabinol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000271	0.00262	CcSEcCtD
Dronabinol—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.00027	0.00261	CcSEcCtD
Dronabinol—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000269	0.00261	CcSEcCtD
Dronabinol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000267	0.00259	CcSEcCtD
Dronabinol—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000266	0.00258	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000264	0.00256	CcSEcCtD
Dronabinol—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000264	0.00255	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000264	0.0166	CbGpPWpGaD
Dronabinol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000262	0.00254	CcSEcCtD
Dronabinol—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000262	0.00253	CcSEcCtD
Dronabinol—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000262	0.00253	CcSEcCtD
Dronabinol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000261	0.00253	CcSEcCtD
Dronabinol—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000258	0.0025	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000258	0.0162	CbGpPWpGaD
Dronabinol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000258	0.0025	CcSEcCtD
Dronabinol—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000258	0.0025	CcSEcCtD
Dronabinol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000258	0.00249	CcSEcCtD
Dronabinol—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000257	0.00249	CcSEcCtD
Dronabinol—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000257	0.00249	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000256	0.00248	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000256	0.0161	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000256	0.00248	CcSEcCtD
Dronabinol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000255	0.00247	CcSEcCtD
Dronabinol—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000254	0.00247	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000254	0.00246	CcSEcCtD
Dronabinol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000253	0.00245	CcSEcCtD
Dronabinol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000253	0.00245	CcSEcCtD
Dronabinol—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000252	0.00244	CcSEcCtD
Dronabinol—Malaise—Etoposide—peripheral nervous system neoplasm	0.00025	0.00242	CcSEcCtD
Dronabinol—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00025	0.00242	CcSEcCtD
Dronabinol—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000247	0.00239	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000245	0.0154	CbGpPWpGaD
Dronabinol—ABCG2—HIF-2-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000243	0.0153	CbGpPWpGaD
Dronabinol—Rash—Topotecan—peripheral nervous system neoplasm	0.000243	0.00235	CcSEcCtD
Dronabinol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000243	0.00235	CcSEcCtD
Dronabinol—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000243	0.00235	CcSEcCtD
Dronabinol—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000243	0.00235	CcSEcCtD
Dronabinol—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000242	0.00235	CcSEcCtD
Dronabinol—Cough—Etoposide—peripheral nervous system neoplasm	0.000242	0.00234	CcSEcCtD
Dronabinol—Headache—Topotecan—peripheral nervous system neoplasm	0.000241	0.00234	CcSEcCtD
Dronabinol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.00234	CcSEcCtD
Dronabinol—Rash—Tretinoin—peripheral nervous system neoplasm	0.000241	0.00234	CcSEcCtD
Dronabinol—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000241	0.00233	CcSEcCtD
Dronabinol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000241	0.00233	CcSEcCtD
Dronabinol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000241	0.00233	CcSEcCtD
Dronabinol—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000241	0.00233	CcSEcCtD
Dronabinol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00024	0.00233	CcSEcCtD
Dronabinol—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.00024	0.00232	CcSEcCtD
Dronabinol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00024	0.00232	CcSEcCtD
Dronabinol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00024	0.00232	CcSEcCtD
Dronabinol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00231	CcSEcCtD
Dronabinol—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00231	CcSEcCtD
Dronabinol—Rash—Melphalan—peripheral nervous system neoplasm	0.000238	0.00231	CcSEcCtD
Dronabinol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000238	0.0023	CcSEcCtD
Dronabinol—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000237	0.0023	CcSEcCtD
Dronabinol—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000235	0.00228	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000234	0.00227	CcSEcCtD
Dronabinol—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000233	0.00226	CcSEcCtD
Dronabinol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000231	0.00223	CcSEcCtD
Dronabinol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00023	0.00223	CcSEcCtD
Dronabinol—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000229	0.00222	CcSEcCtD
Dronabinol—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000228	0.00221	CcSEcCtD
Dronabinol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000228	0.00221	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000225	0.00218	CcSEcCtD
Dronabinol—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Dronabinol—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000224	0.00217	CcSEcCtD
Dronabinol—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000221	0.00214	CcSEcCtD
Dronabinol—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000221	0.00214	CcSEcCtD
Dronabinol—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.00022	0.00213	CcSEcCtD
Dronabinol—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000219	0.00212	CcSEcCtD
Dronabinol—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000216	0.00209	CcSEcCtD
Dronabinol—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000215	0.00208	CcSEcCtD
Dronabinol—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.00207	CcSEcCtD
Dronabinol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.00207	CcSEcCtD
Dronabinol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000211	0.00205	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.00021	0.0132	CbGpPWpGaD
Dronabinol—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00201	CcSEcCtD
Dronabinol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000206	0.00199	CcSEcCtD
Dronabinol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.00199	CcSEcCtD
Dronabinol—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000203	0.0128	CbGpPWpGaD
Dronabinol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00197	CcSEcCtD
Dronabinol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000201	0.00195	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.000201	0.0126	CbGpPWpGaD
Dronabinol—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0002	0.00194	CcSEcCtD
Dronabinol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000199	0.00193	CcSEcCtD
Dronabinol—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00192	CcSEcCtD
Dronabinol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.00191	CcSEcCtD
Dronabinol—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000197	0.0019	CcSEcCtD
Dronabinol—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000195	0.00189	CcSEcCtD
Dronabinol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000193	0.00187	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000192	0.0121	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000192	0.0121	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	0.000192	0.0121	CbGpPWpGaD
Dronabinol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00186	CcSEcCtD
Dronabinol—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000191	0.00185	CcSEcCtD
Dronabinol—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00185	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.00019	0.0119	CbGpPWpGaD
Dronabinol—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.00181	CcSEcCtD
Dronabinol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000186	0.00181	CcSEcCtD
Dronabinol—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000185	0.00179	CcSEcCtD
Dronabinol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000185	0.00179	CcSEcCtD
Dronabinol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000184	0.00178	CcSEcCtD
Dronabinol—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000183	0.0115	CbGpPWpGaD
Dronabinol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00177	CcSEcCtD
Dronabinol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.00177	CcSEcCtD
Dronabinol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000182	0.00176	CcSEcCtD
Dronabinol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.00176	CcSEcCtD
Dronabinol—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00173	CcSEcCtD
Dronabinol—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000179	0.00173	CcSEcCtD
Dronabinol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.00173	CcSEcCtD
Dronabinol—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000177	0.00172	CcSEcCtD
Dronabinol—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.00171	CcSEcCtD
Dronabinol—Rash—Vincristine—peripheral nervous system neoplasm	0.000176	0.00171	CcSEcCtD
Dronabinol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000176	0.0017	CcSEcCtD
Dronabinol—Headache—Vincristine—peripheral nervous system neoplasm	0.000175	0.00169	CcSEcCtD
Dronabinol—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	0.000173	0.0109	CbGpPWpGaD
Dronabinol—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.00167	CcSEcCtD
Dronabinol—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.00164	CcSEcCtD
Dronabinol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000167	0.00161	CcSEcCtD
Dronabinol—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000166	0.00161	CcSEcCtD
Dronabinol—CNR2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000166	0.0104	CbGpPWpGaD
Dronabinol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000166	0.0016	CcSEcCtD
Dronabinol—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.0016	CcSEcCtD
Dronabinol—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000162	0.00157	CcSEcCtD
Dronabinol—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000161	0.00156	CcSEcCtD
Dronabinol—Chills—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00155	CcSEcCtD
Dronabinol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00016	0.00155	CcSEcCtD
Dronabinol—Rash—Cisplatin—peripheral nervous system neoplasm	0.000156	0.00151	CcSEcCtD
Dronabinol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000156	0.00151	CcSEcCtD
Dronabinol—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000155	0.0015	CcSEcCtD
Dronabinol—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00149	CcSEcCtD
Dronabinol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.00148	CcSEcCtD
Dronabinol—Tension—Epirubicin—peripheral nervous system neoplasm	0.000152	0.00148	CcSEcCtD
Dronabinol—CNR2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000151	0.00949	CbGpPWpGaD
Dronabinol—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000151	0.00146	CcSEcCtD
Dronabinol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00015	0.00145	CcSEcCtD
Dronabinol—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.00144	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000149	0.00937	CbGpPWpGaD
Dronabinol—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.00144	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000145	0.00909	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.0014	CcSEcCtD
Dronabinol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—ABCB1—peripheral nervous system neoplasm	0.000143	0.00901	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	0.000143	0.009	CbGpPWpGaD
Dronabinol—Rash—Etoposide—peripheral nervous system neoplasm	0.000143	0.00138	CcSEcCtD
Dronabinol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000142	0.00138	CcSEcCtD
Dronabinol—Headache—Etoposide—peripheral nervous system neoplasm	0.000142	0.00137	CcSEcCtD
Dronabinol—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00137	CcSEcCtD
Dronabinol—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00136	CcSEcCtD
Dronabinol—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.00135	CcSEcCtD
Dronabinol—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00133	CcSEcCtD
Dronabinol—Cough—Epirubicin—peripheral nervous system neoplasm	0.000136	0.00131	CcSEcCtD
Dronabinol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000135	0.0013	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000134	0.00842	CbGpPWpGaD
Dronabinol—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.00129	CcSEcCtD
Dronabinol—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00128	CcSEcCtD
Dronabinol—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000132	0.00128	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00127	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000131	0.00825	CbGpPWpGaD
Dronabinol—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000131	0.00127	CcSEcCtD
Dronabinol—CNR1—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.00013	0.00819	CbGpPWpGaD
Dronabinol—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.00126	CcSEcCtD
Dronabinol—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000129	0.00125	CcSEcCtD
Dronabinol—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000128	0.00124	CcSEcCtD
Dronabinol—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00123	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	0.000126	0.00791	CbGpPWpGaD
Dronabinol—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00122	CcSEcCtD
Dronabinol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00121	CcSEcCtD
Dronabinol—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000124	0.0012	CcSEcCtD
Dronabinol—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.0012	CcSEcCtD
Dronabinol—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00119	CcSEcCtD
Dronabinol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—HSD17B12—peripheral nervous system neoplasm	0.000123	0.00773	CbGpPWpGaD
Dronabinol—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00119	CcSEcCtD
Dronabinol—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00119	CcSEcCtD
Dronabinol—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00118	CcSEcCtD
Dronabinol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.00118	CcSEcCtD
Dronabinol—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00117	CcSEcCtD
Dronabinol—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.00117	CcSEcCtD
Dronabinol—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.00116	CcSEcCtD
Dronabinol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000118	0.00115	CcSEcCtD
Dronabinol—CNR1—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	0.000118	0.00745	CbGpPWpGaD
Dronabinol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.00115	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00112	CcSEcCtD
Dronabinol—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00111	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	0.000115	0.00723	CbGpPWpGaD
Dronabinol—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.00111	CcSEcCtD
Dronabinol—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.0011	CcSEcCtD
Dronabinol—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.0011	CcSEcCtD
Dronabinol—CNR1—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	0.000113	0.00713	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—ABCB1—peripheral nervous system neoplasm	0.000113	0.0071	CbGpPWpGaD
Dronabinol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000113	0.00109	CcSEcCtD
Dronabinol—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.00108	CcSEcCtD
Dronabinol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000112	0.00702	CbGpPWpGaD
Dronabinol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	0.000111	0.007	CbGpPWpGaD
Dronabinol—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00107	CcSEcCtD
Dronabinol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.00106	CcSEcCtD
Dronabinol—CNR2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	0.00011	0.00689	CbGpPWpGaD
Dronabinol—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000109	0.00106	CcSEcCtD
Dronabinol—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00104	CcSEcCtD
Dronabinol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000104	0.00101	CcSEcCtD
Dronabinol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00101	CcSEcCtD
Dronabinol—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000104	0.001	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—NTS—peripheral nervous system neoplasm	0.000103	0.00648	CbGpPWpGaD
Dronabinol—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000988	CcSEcCtD
Dronabinol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000102	0.0064	CbGpPWpGaD
Dronabinol—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.00098	CcSEcCtD
Dronabinol—CNR2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	0.0001	0.00632	CbGpPWpGaD
Dronabinol—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000971	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	9.95e-05	0.00626	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	9.87e-05	0.00621	CbGpPWpGaD
Dronabinol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	9.7e-05	0.0061	CbGpPWpGaD
Dronabinol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000937	CcSEcCtD
Dronabinol—CNR1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	9.61e-05	0.00604	CbGpPWpGaD
Dronabinol—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000929	CcSEcCtD
Dronabinol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000905	CcSEcCtD
Dronabinol—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.27e-05	0.000898	CcSEcCtD
Dronabinol—CNR2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	9.18e-05	0.00577	CbGpPWpGaD
Dronabinol—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000881	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	9.02e-05	0.00567	CbGpPWpGaD
Dronabinol—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.97e-05	0.000869	CcSEcCtD
Dronabinol—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.00084	CcSEcCtD
Dronabinol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	8.64e-05	0.000837	CcSEcCtD
Dronabinol—CNR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	8.6e-05	0.00541	CbGpPWpGaD
Dronabinol—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000815	CcSEcCtD
Dronabinol—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000812	CcSEcCtD
Dronabinol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000804	CcSEcCtD
Dronabinol—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000778	CcSEcCtD
Dronabinol—Rash—Epirubicin—peripheral nervous system neoplasm	8e-05	0.000774	CcSEcCtD
Dronabinol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.000774	CcSEcCtD
Dronabinol—Headache—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000769	CcSEcCtD
Dronabinol—CNR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	7.89e-05	0.00496	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	7.81e-05	0.00491	CbGpPWpGaD
Dronabinol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000752	CcSEcCtD
Dronabinol—CNR2—Signaling Pathways—NTS—peripheral nervous system neoplasm	7.75e-05	0.00488	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	7.73e-05	0.00486	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CD55—peripheral nervous system neoplasm	7.43e-05	0.00468	CbGpPWpGaD
Dronabinol—Rash—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000717	CcSEcCtD
Dronabinol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000716	CcSEcCtD
Dronabinol—Headache—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000712	CcSEcCtD
Dronabinol—CNR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	7.2e-05	0.00453	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	6.95e-05	0.00437	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	6.89e-05	0.00433	CbGpPWpGaD
Dronabinol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	6.71e-05	0.00422	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	6.49e-05	0.00408	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	6.49e-05	0.00408	CbGpPWpGaD
Dronabinol—ABCG2—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	6.4e-05	0.00403	CbGpPWpGaD
Dronabinol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	6.39e-05	0.00402	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	6.08e-05	0.00383	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	5.9e-05	0.00371	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	5.89e-05	0.00371	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—VIP—peripheral nervous system neoplasm	5.88e-05	0.0037	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	5.83e-05	0.00367	CbGpPWpGaD
Dronabinol—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	5.82e-05	0.00366	CbGpPWpGaD
Dronabinol—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	5.68e-05	0.00358	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	5.68e-05	0.00357	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	5.42e-05	0.00341	CbGpPWpGaD
Dronabinol—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	5.28e-05	0.00332	CbGpPWpGaD
Dronabinol—CNR1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	5.2e-05	0.00327	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	5.16e-05	0.00324	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	5.1e-05	0.00321	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.89e-05	0.00308	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.77e-05	0.003	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	4.63e-05	0.00291	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	4.61e-05	0.0029	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.59e-05	0.00288	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.58e-05	0.00288	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	4.46e-05	0.0028	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	4.35e-05	0.00273	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.33e-05	0.00272	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	4.26e-05	0.00268	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	4.07e-05	0.00256	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	4.05e-05	0.00255	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	4.05e-05	0.00255	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4e-05	0.00252	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.65e-05	0.0023	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	3.58e-05	0.00225	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	3.48e-05	0.00219	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	3.32e-05	0.00209	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.23e-05	0.00203	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.22e-05	0.00203	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	3.2e-05	0.00201	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.18e-05	0.002	CbGpPWpGaD
Dronabinol—CYP1A1—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	3.18e-05	0.002	CbGpPWpGaD
Dronabinol—ABCG2—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	3.11e-05	0.00195	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.09e-05	0.00195	CbGpPWpGaD
Dronabinol—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.07e-05	0.00193	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	3.05e-05	0.00192	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.93e-05	0.00184	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	2.9e-05	0.00182	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.81e-05	0.00177	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.73e-05	0.00172	CbGpPWpGaD
Dronabinol—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	2.69e-05	0.00169	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	2.65e-05	0.00167	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.64e-05	0.00166	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.61e-05	0.00164	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.58e-05	0.00162	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.57e-05	0.00162	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.48e-05	0.00156	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.43e-05	0.00153	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.41e-05	0.00151	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.39e-05	0.0015	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GNS—peripheral nervous system neoplasm	2.33e-05	0.00146	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GNS—peripheral nervous system neoplasm	2.24e-05	0.00141	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—NME1—peripheral nervous system neoplasm	2.23e-05	0.0014	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.18e-05	0.00137	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.15e-05	0.00136	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—COX2—peripheral nervous system neoplasm	2.15e-05	0.00135	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—NME1—peripheral nervous system neoplasm	2.14e-05	0.00135	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.12e-05	0.00133	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	2.11e-05	0.00133	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—COX2—peripheral nervous system neoplasm	2.06e-05	0.0013	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	2.03e-05	0.00128	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.95e-05	0.00123	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	1.95e-05	0.00123	CbGpPWpGaD
Dronabinol—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.92e-05	0.00121	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.81e-05	0.00114	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.78e-05	0.00112	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.74e-05	0.00109	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.69e-05	0.00106	CbGpPWpGaD
Dronabinol—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.68e-05	0.00106	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.67e-05	0.00105	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.66e-05	0.00104	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.63e-05	0.00102	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.59e-05	0.000999	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.58e-05	0.000992	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.58e-05	0.000991	CbGpPWpGaD
Dronabinol—CNR2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.53e-05	0.000964	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.52e-05	0.000955	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.51e-05	0.00095	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.48e-05	0.000932	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.46e-05	0.000919	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.45e-05	0.000915	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.41e-05	0.000887	CbGpPWpGaD
Dronabinol—CNR2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000875	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000852	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.35e-05	0.00085	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.33e-05	0.000834	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.000826	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.31e-05	0.000825	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.29e-05	0.000811	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.28e-05	0.000806	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.27e-05	0.000801	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.26e-05	0.000792	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.24e-05	0.000778	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.24e-05	0.000778	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.21e-05	0.000759	CbGpPWpGaD
Dronabinol—CNR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000757	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.19e-05	0.00075	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.19e-05	0.000749	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.19e-05	0.000748	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.19e-05	0.000746	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.18e-05	0.000739	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.16e-05	0.000731	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—BCHE—peripheral nervous system neoplasm	1.14e-05	0.00072	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000715	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.13e-05	0.000709	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.12e-05	0.000705	CbGpPWpGaD
Dronabinol—CNR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000687	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.09e-05	0.000687	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.09e-05	0.000682	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000681	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.000677	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.07e-05	0.000675	CbGpPWpGaD
Dronabinol—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.06e-05	0.000664	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.04e-05	0.000651	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.00065	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	0.00064	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.99e-06	0.000628	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.74e-06	0.000612	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	9.55e-06	0.0006	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.31e-06	0.000586	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.3e-06	0.000585	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	9.15e-06	0.000575	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.98e-06	0.000564	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—GNAS—peripheral nervous system neoplasm	8.79e-06	0.000553	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—ABCB1—peripheral nervous system neoplasm	8.62e-06	0.000542	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	8.5e-06	0.000535	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	8.31e-06	0.000523	CbGpPWpGaD
Dronabinol—CNR2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.22e-06	0.000517	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.15e-06	0.000513	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	8.07e-06	0.000507	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.81e-06	0.000491	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.75e-06	0.000488	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.7e-06	0.000484	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.64e-06	0.000481	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	7.63e-06	0.00048	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	7.58e-06	0.000477	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	7.43e-06	0.000468	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.31e-06	0.00046	CbGpPWpGaD
Dronabinol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	7.18e-06	0.000451	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	7.16e-06	0.00045	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	7.12e-06	0.000448	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.6e-06	0.000415	CbGpPWpGaD
Dronabinol—CNR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.45e-06	0.000406	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	6.44e-06	0.000405	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.3e-06	0.000396	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	6.21e-06	0.00039	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.19e-06	0.000389	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.15e-06	0.000387	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.08e-06	0.000382	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.06e-06	0.000381	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.02e-06	0.000379	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.74e-06	0.000361	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.66e-06	0.000356	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.07e-06	0.000319	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.97e-06	0.000313	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.95e-06	0.000311	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.7e-06	0.000295	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.62e-06	0.000291	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.53e-06	0.000285	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.97e-06	0.00025	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.79e-06	0.000238	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.73e-06	0.000235	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.05e-06	0.000192	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.99e-06	0.000188	CbGpPWpGaD
Dronabinol—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.47e-06	0.000155	CbGpPWpGaD
Dronabinol—PTGS1—Metabolism—AKT1—peripheral nervous system neoplasm	2.37e-06	0.000149	CbGpPWpGaD
Dronabinol—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	2.24e-06	0.000141	CbGpPWpGaD
Dronabinol—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.67e-06	0.000105	CbGpPWpGaD
Dronabinol—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.37e-06	8.6e-05	CbGpPWpGaD
Dronabinol—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.33e-06	8.39e-05	CbGpPWpGaD
Dronabinol—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-06	7.84e-05	CbGpPWpGaD
Dronabinol—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	8.22e-07	5.17e-05	CbGpPWpGaD
